DK164283A - Polypeptide having cystatin C activity, DNA sequence for expressing 3-des-OH-cystatin C or a modification thereof, process for preparing 3-des-hydroxy-cystatin C or a modification thereof, plasmid and microorganisms for implementing the process, and the use of 3-des-OH- cystatin C or a modification thereof for producing a therapeutic preparation - Google Patents

Polypeptide having cystatin C activity, DNA sequence for expressing 3-des-OH-cystatin C or a modification thereof, process for preparing 3-des-hydroxy-cystatin C or a modification thereof, plasmid and microorganisms for implementing the process, and the use of 3-des-OH- cystatin C or a modification thereof for producing a therapeutic preparation Download PDF

Info

Publication number
DK164283A
DK164283A DK164283A DK164283A DK164283A DK 164283 A DK164283 A DK 164283A DK 164283 A DK164283 A DK 164283A DK 164283 A DK164283 A DK 164283A DK 164283 A DK164283 A DK 164283A
Authority
DK
Denmark
Prior art keywords
cystatin
des
modification
plasmid
microorganisms
Prior art date
Application number
DK164283A
Other languages
Danish (da)
Other versions
DK164283D0 (en
Inventor
Barbara Joyce Broughton
Martin Arthur Heazell
Libert Clinton Saunders
Peter James Warne
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of DK164283D0 publication Critical patent/DK164283D0/en
Publication of DK164283A publication Critical patent/DK164283A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK164283A 1982-04-15 1983-04-14 Polypeptide having cystatin C activity, DNA sequence for expressing 3-des-OH-cystatin C or a modification thereof, process for preparing 3-des-hydroxy-cystatin C or a modification thereof, plasmid and microorganisms for implementing the process, and the use of 3-des-OH- cystatin C or a modification thereof for producing a therapeutic preparation DK164283A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8210927 1982-04-15

Publications (2)

Publication Number Publication Date
DK164283D0 DK164283D0 (en) 1983-04-14
DK164283A true DK164283A (en) 1983-10-16

Family

ID=10529707

Family Applications (1)

Application Number Title Priority Date Filing Date
DK164283A DK164283A (en) 1982-04-15 1983-04-14 Polypeptide having cystatin C activity, DNA sequence for expressing 3-des-OH-cystatin C or a modification thereof, process for preparing 3-des-hydroxy-cystatin C or a modification thereof, plasmid and microorganisms for implementing the process, and the use of 3-des-OH- cystatin C or a modification thereof for producing a therapeutic preparation

Country Status (18)

Country Link
JP (1) JPS58188865A (en)
KR (1) KR840004407A (en)
AT (1) ATA135183A (en)
AU (1) AU1350883A (en)
BE (1) BE896465A (en)
DE (1) DE3313599A1 (en)
DK (1) DK164283A (en)
ES (2) ES8504139A1 (en)
FI (1) FI831258L (en)
FR (1) FR2525218A1 (en)
GB (1) GB2119790A (en)
GR (1) GR78209B (en)
IL (1) IL68405A0 (en)
IT (1) IT1164173B (en)
LU (1) LU84747A1 (en)
NL (1) NL8301310A (en)
SE (1) SE8302084L (en)
ZA (1) ZA832638B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2617478B1 (en) * 1987-07-01 1990-01-05 Esteve Labor Dr NOVEL ARYL-HETEROARYL CETONES DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6288100B1 (en) * 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
FR2751649B1 (en) * 1996-07-26 1998-08-28 Adir NOVEL DERIVATIVES OF BENZIMIDAZOLE, BENZOXAZOLE AND BENZOTHIAZOLE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH528514A (en) * 1969-05-22 1972-09-30 Bayer Ag Process for the preparation of acylimidazoles
FR2257269B1 (en) * 1973-10-03 1978-12-29 Delalande Sa

Also Published As

Publication number Publication date
LU84747A1 (en) 1983-12-05
SE8302084L (en) 1983-10-16
ZA832638B (en) 1983-12-28
ES523937A0 (en) 1984-11-01
SE8302084D0 (en) 1983-04-14
FI831258L (en) 1983-10-16
FR2525218A1 (en) 1983-10-21
GB8310146D0 (en) 1983-05-18
GB2119790A (en) 1983-11-23
ATA135183A (en) 1985-05-15
ES521460A0 (en) 1985-04-01
IL68405A0 (en) 1983-07-31
IT8320578A0 (en) 1983-04-14
NL8301310A (en) 1983-11-01
GR78209B (en) 1984-09-26
KR840004407A (en) 1984-10-15
ES8500909A1 (en) 1984-11-01
JPS58188865A (en) 1983-11-04
AU1350883A (en) 1983-10-20
DE3313599A1 (en) 1983-10-20
ES8504139A1 (en) 1985-04-01
BE896465A (en) 1983-10-14
FI831258A0 (en) 1983-04-14
IT1164173B (en) 1987-04-08
DK164283D0 (en) 1983-04-14

Similar Documents

Publication Publication Date Title
DE3572179D1 (en) Blood coagulation inhibiting proteins, process for preparing them and their use
IL71274A (en) Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciffrol
ZA852639B (en) Implantable formulations of regulatory peptides with controlled release,and process for their preparation
EP0161632A3 (en) Pyrrolo-benzimidazoles, process for their preparation, medicaments containing them and intermediates
ZA882452B (en) Use of n,n-dialkylhydroxylamines and their preparation
PL229123A1 (en) Dna sequences,molecules of dna recombinants and methodsof preparing the polypeptides resembling the human interferon
EP0187620A3 (en) Pyrrolo-pyrroles, process for their preparation and use
PT79917B (en) Process for preparing new renin- inhibotory peptides and their use
AR243877A1 (en) Aminoacyllabdanes, a process and intermediates for their preparation and their use as medicaments
ZA816993B (en) New galenical preparation of metoclopramide,process for preparing the same and medicament comprising this preparation
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
DE3168902D1 (en) Epoxy-cycloalkylalkanecarboxylic acids, process for their preparation, their use and medicaments containing them
AR244216A1 (en) Iminophenylthiazolidines, process of preparation, and method of use
DE3361701D1 (en) Process for the preparation of polyester resins containing phosphoric-acid groups, and their use
DK164283A (en) Polypeptide having cystatin C activity, DNA sequence for expressing 3-des-OH-cystatin C or a modification thereof, process for preparing 3-des-hydroxy-cystatin C or a modification thereof, plasmid and microorganisms for implementing the process, and the use of 3-des-OH- cystatin C or a modification thereof for producing a therapeutic preparation
DE3060962D1 (en) Peptides having thymopoietin-like activity, therapeutic compositions containing them, and process for their preparation
ZA879694B (en) Novel carbamoyloxylabdanes,intermediates and a process for the preparation thereof and their use as medicaments
GB2179858B (en) Compositions for treating viral skin diseases.
EP0121081A3 (en) Azolylmethylcycloalkanes, process for their preparation and their therapeutical use
EP0156341A3 (en) Treatment of ultrafiltrate by electrodialysis
NZ218720A (en) Method of preparing biological material, by freezing and grinding
EP0270682A4 (en) Novel complexes, process for their preparation, and medicinal use of them.
ZW24886A1 (en) New ortho-anisamides,process for their preparation and their therapeutic applications
AR241906A1 (en) Benzamides, process for their preparation and their therapeutical use
EP0253413A3 (en) New antibiotics called "mureidomycins a, b, c and d" a process for their preparation and their therapeutic use

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment